Assessment of Sleep Apnea in Pediatric Patients
In-laboratory polysomnography (PSG) is the required diagnostic test for pediatric obstructive sleep apnea, and home sleep apnea testing should not be used in children. 1
Screening Approach
All children must be screened for snoring during every routine health maintenance visit. 1 If habitual snoring is absent, obstructive sleep apnea (OSA) is unlikely and further workup is not needed. 1 When habitual snoring is present, proceed immediately to detailed clinical evaluation. 1
Clinical History Red Flags
Obtain specific history for these high-risk features that predict OSA requiring intervention:
- Airway obstruction during sleep: Difficulty breathing during sleep (96% sensitivity for OSA), observed apnea episodes (78% sensitivity), and apneas described as "frightening to observer" by parents 1, 2, 3
- Nocturnal symptoms: Restless sleep, nocturnal enuresis, snoring 4, 3
- Daytime symptoms: Intrusive naps, mouth breathing when awake, chronic rhinorrhea 4, 3
Physical Examination Findings
Target these specific anatomical and physiologic markers:
- Tonsillar size: Tonsils nearly touching or touching in midline 1
- Craniofacial features: Adenoidal facies, micrognathia/retrognathia, high-arched palate 1
- Body habitus: BMI ≥95th percentile for age/sex 1
- Respiratory pattern: Mouth breathing, signs of chronic nasal obstruction 4, 3
Diagnostic Testing Algorithm
Step 1: If clinical suspicion for OSA exists based on screening and examination, refer directly for in-laboratory polysomnography. 1 Do not rely on clinical assessment alone—this is a critical pitfall that delays diagnosis and allows progression of serious complications including neurocognitive impairment, behavioral problems, and death. 1
Step 2: PSG measures these essential parameters that define OSA severity:
- Apnea-Hypopnea Index (AHI): ≥1 event/hour is diagnostic for OSA in children 1, 2
- Oxygen saturation: Lowest SpO2 during any event, with <80% indicating high perioperative risk regardless of AHI 2
- CO2 monitoring: Peak PCO2 ≥60 mmHg during any event or obstructive hypoventilation (≥25% of sleep time with PaCO2 >50 mmHg) 1, 2
- Arousal detection: Frequent arousals disrupting sleep architecture 2
Why Home Sleep Testing Fails in Children
Home sleep apnea tests are explicitly not recommended for pediatric diagnosis because they cannot monitor CO2 levels, cannot detect arousals, have high false-negative rates, and lack validation in pediatric populations. 1, 5, 2 Even though some research suggests portable monitors may detect severe OSA in older children 6, guidelines uniformly reject this approach because missing central apnea and hypoventilation leads to dangerous underdiagnosis. 5
Severity Classification After PSG
Once PSG is completed, classify severity to guide treatment urgency:
- Mild OSA: AHI 1-5 events/hour 1, 2
- Moderate OSA: AHI 6-10 events/hour 1, 2
- Severe OSA: AHI >10 events/hour 1, 2
Critical upgrade rule: Automatically upgrade severity classification if ANY single event shows lowest oxygen saturation <80%, peak PCO2 ≥60 mmHg, or parent-described "frightening" apneas, because individual severe events predict respiratory compromise independent of frequency. 2
Special Considerations for Infants
In full-term infants with apnea, PSG remains the gold standard to differentiate central, obstructive, and mixed apnea types. 5 Even brief apnea episodes in full-term infants are pathological until proven otherwise and require thorough evaluation including complete medical history, physical examination, and laboratory tests to rule out respiratory, neurological, or cardiovascular disorders. 5
Common Pitfalls to Avoid
- Never delay PSG while attempting clinical scoring systems or questionnaires—these may help prioritize referrals but cannot replace objective testing 1, 7
- Never use lateral neck radiographs alone for diagnosis, though adenoid hypertrophy on imaging combined with mouth breathing or nocturnal enuresis has 90% sensitivity for screening 4
- Never assume obesity predicts adenotonsillectomy failure—obese children may have less satisfactory results but many still benefit, requiring clinical judgment 1